180 related articles for article (PubMed ID: 34395284)
1. CDK4: A Novel Therapeutic Target for Extramammary Paget's Disease.
Hashimoto H; Kaku-Ito Y; Oda Y; Ito T
Front Oncol; 2021; 11():710378. PubMed ID: 34395284
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclin-dependent kinase 4 protein in extramammary Paget's disease.
Urata K; Kajihara I; Myangat TM; Tasaki Y; Otsuka-Maeda S; Sawamura S; Kanazawa-Yamada S; Sakamoto R; Makino K; Aoi J; Igata T; Makino T; Masuguchi S; Fukushima S; Jinnin M; Ihn H
J Dermatol; 2019 May; 46(5):444-448. PubMed ID: 30897229
[TBL] [Abstract][Full Text] [Related]
4. The expression of EpCAM in extramammary Paget's disease.
Yamada-Kanazawa S; Tasaki Y; Kajihara I; Sakamoto R; Maeda-Otsuka S; Ihn H
Intractable Rare Dis Res; 2019 Feb; 8(1):20-23. PubMed ID: 30881853
[TBL] [Abstract][Full Text] [Related]
5. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
6. Expression of the p38 MAPK, NF-kappaB and cyclin D1 in extramammary Paget's disease.
Lin N; Uchi H; Moroi Y; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
J Dermatol Sci; 2007 Mar; 45(3):187-92. PubMed ID: 17207971
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J
J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343
[TBL] [Abstract][Full Text] [Related]
9. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of treatment options for extramammary Paget's disease: a SEER database analysis.
Ma X; Li Y
Transl Cancer Res; 2021 Jun; 10(6):2873-2881. PubMed ID: 35116597
[TBL] [Abstract][Full Text] [Related]
11. Primary extramammary Paget's disease: a clinicopathological study of 28 cases.
Zhao Y; Gong X; Li N; Zhu Q; Yu D; Jin X
Int J Clin Exp Pathol; 2019; 12(9):3426-3432. PubMed ID: 31934186
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Janus kinase 2 protein in extramammary Paget's disease.
Otsuka-Maeda S; Mijiddorj MT; Kajihara I; Sakamoto R; Yamada-Kanazawa S; Kanemaru H; Nishimura Y; Sawamura S; Makino K; Aoi J; Makino T; Masuguchi S; Fukushima S; Ihn H
Jpn J Clin Oncol; 2021 Jul; 51(7):1176-1178. PubMed ID: 33912910
[TBL] [Abstract][Full Text] [Related]
13. Definition, Association with Malignancy, Biologic Behavior, and Treatment of Ectopic Extramammary Paget's Disease: A Review of the Literature.
Scarbrough CA; Vrable A; Carr DR
J Clin Aesthet Dermatol; 2019 Aug; 12(8):40-44. PubMed ID: 31531170
[No Abstract] [Full Text] [Related]
14. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
[TBL] [Abstract][Full Text] [Related]
15. Upregulated expression of glucose transporter isoform 1 in invasive and metastatic extramammary Paget's disease.
Matsumoto M; Rokunohe D; Sasaki T; Matsuzaki Y; Nakano H; Mizukami H; Akasaka E; Sawamura D
Exp Ther Med; 2024 May; 27(5):228. PubMed ID: 38596658
[TBL] [Abstract][Full Text] [Related]
16. Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.
Hashimoto H; Kaku-Ito Y; Furue M; Ito T
Front Oncol; 2021; 11():642919. PubMed ID: 33937045
[TBL] [Abstract][Full Text] [Related]
17. Extramammary Paget's Disease in Two Brothers.
Zhang X; Jin W; Zhu H; Yu H
Indian J Dermatol; 2015; 60(4):423. PubMed ID: 26288451
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.
Fukuda K; Funakoshi T
Front Oncol; 2018; 8():38. PubMed ID: 29503810
[TBL] [Abstract][Full Text] [Related]
19. A Positive Dermcidin Expression Is an Unfavorable Prognostic Marker for Extramammary Paget's Disease.
Ohmori S; Sawada Y; Saito-Sasaki N; Sato S; Minokawa Y; Sugino H; Nanamori H; Yamamoto K; Okada E; Nakamura M
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34198581
[TBL] [Abstract][Full Text] [Related]
20. The expression of HER-2 in extramammary Paget's disease.
Masuguchi S; Jinnin M; Fukushima S; Makino T; Sakai K; Inoue Y; Igata T; Ihn H
Biosci Trends; 2011 Aug; 5(4):151-5. PubMed ID: 21914949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
